Rhythm Biosciences Says Australian Laboratory Accreditation Body Confirms Colorectal Cancer Test Meets Standard; Shares Rise 8%

MT Newswires Live

Mar 09

Rhythm Biosciences (ASX:RHY) said the National Association of Testing Authorities confirmed that its ColoSTAT blood-based colorectal cancer test satisfies all applicable technical and quality requirements under the ISO 15189:2022 standard, according to a Monday Australian bourse filing.

The test's validation and intended clinical application were reviewed in accordance with the National Pathology Accreditation Advisory Council requirements. ColoSTAT was formally listed within the accredited scope of Rhythm's laboratory in Parkville, Victoria.

Its shares jumped 8% in recent trading on Monday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2618930616"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2618930616\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2618930616?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-09 11:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2618930616","market":"fut","top_or_hot":-1,"title":"Rhythm Biosciences Says Australian Laboratory Accreditation Body Confirms Colorectal Cancer Test Meets Standard; Shares Rise 8%","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/RHYN.AU\">Rhythm Biosciences</a> (ASX:RHY) said the National Association of Testing Authorities confirmed that its ColoSTAT blood-based colorectal cancer test satisfies all applicable technical and quality requirements under the ISO 15189:2022 standard, according to a Monday Australian bourse filing.</p><p>The test's validation and intended clinical application were reviewed in accordance with the National Pathology Accreditation Advisory Council requirements. ColoSTAT was formally listed within the accredited scope of Rhythm's laboratory in Parkville, <a href=\"https://laohu8.com/S/VCCTF\">Victoria</a>.</p><p>Its shares jumped 8% in recent trading on Monday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rhythm Biosciences Says Australian Laboratory Accreditation Body Confirms Colorectal Cancer Test Meets Standard; Shares Rise 8%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRhythm Biosciences Says Australian Laboratory Accreditation Body Confirms Colorectal Cancer Test Meets Standard; Shares Rise 8%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-03-09 11:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/RHYN.AU\">Rhythm Biosciences</a> (ASX:RHY) said the National Association of Testing Authorities confirmed that its ColoSTAT blood-based colorectal cancer test satisfies all applicable technical and quality requirements under the ISO 15189:2022 standard, according to a Monday Australian bourse filing.</p><p>The test's validation and intended clinical application were reviewed in accordance with the National Pathology Accreditation Advisory Council requirements. ColoSTAT was formally listed within the accredited scope of Rhythm's laboratory in Parkville, <a href=\"https://laohu8.com/S/VCCTF\">Victoria</a>.</p><p>Its shares jumped 8% in recent trading on Monday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XKO.AU","symbol_name":"标普/澳交所 300指数","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2618930616","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2618930616","pubTimestamp":1773026565,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Rhythm Biosciences  said the National Association of Testing Authorities confirmed that its ColoSTAT blood-based colorectal cancer test satisfies all applicable technical and quality requirements under the ISO 15189:2022 standard, according to a Monday Australian bourse filing.The test's validation and intended clinical application were reviewed in accordance with the National Pathology Accreditation Advisory Council requirements. ColoSTAT was formally listed within the accredited scope of Rhythm's laboratory in Parkville, Victoria.Its shares jumped 8% in recent trading on Monday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"XKO.AU":"标普/澳交所 300指数","BK4124":"机动车零配件与设备","BK7124":"保健护理服务","SMP":"Standard Motor Products Inc","XAO.AU":"标普/澳交所 普通股指数","XJO.AU":"标普/澳交所 200指数","RHY.AU":"RHYTHM BIOSCIENCES LTD"},"translate_title":"Rhythm Biosciences表示澳大利亚实验室认证机构确认结直肠癌检测符合标准；股价上涨8%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XAO.AU":1.5,"XKO.AU":1.5,"SMP":1.5,"XJO.AU":1.5,"RHY.AU":1},"content_text":"Rhythm Biosciences (ASX:RHY) said the National Association of Testing Authorities confirmed that its ColoSTAT blood-based colorectal cancer test satisfies all applicable technical and quality requirements under the ISO 15189:2022 standard, according to a Monday Australian bourse filing.The test's validation and intended clinical application were reviewed in accordance with the National Pathology Accreditation Advisory Council requirements. ColoSTAT was formally listed within the accredited scope of Rhythm's laboratory in Parkville, Victoria.Its shares jumped 8% in recent trading on Monday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}